BeiGene Ltd (BGNE)
162.25
+0.24
(+0.15%)
USD |
NASDAQ |
May 03, 16:00
161.97
-0.28
(-0.17%)
After-Hours: 20:00
BeiGene Gross Profit Margin (Quarterly): 83.32% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 83.32% |
| September 30, 2023 | 87.67% |
| June 30, 2023 | 83.87% |
| March 31, 2023 | 81.74% |
| December 31, 2022 | 80.66% |
| September 30, 2022 | 80.25% |
| June 30, 2022 | 79.16% |
| March 31, 2022 | 78.72% |
| December 31, 2021 | 77.31% |
| September 30, 2021 | 77.03% |
| June 30, 2021 | 75.82% |
| March 31, 2021 | 94.61% |
| December 31, 2020 | 78.94% |
| Date | Value |
|---|---|
| September 30, 2020 | 76.81% |
| June 30, 2020 | 78.20% |
| March 31, 2020 | 72.82% |
| December 31, 2019 | 68.39% |
| September 30, 2019 | 59.90% |
| June 30, 2019 | 92.67% |
| March 31, 2019 | 80.39% |
| December 31, 2018 | 84.33% |
| September 30, 2018 | 83.94% |
| June 30, 2018 | 88.15% |
| March 31, 2018 | 86.02% |
| December 31, 2017 | 83.33% |
| September 30, 2017 | 99.12% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
59.90%
Minimum
Sep 2019
94.61%
Maximum
Mar 2021
79.36%
Average
78.94%
Median
Dec 2020
Gross Profit Margin (Quarterly) Benchmarks
| Theravance Biopharma Inc | -- |
| LumiraDx Ltd | -47.14% |
| Dr Reddy's Laboratories Ltd | 58.50% |
| ASLAN Pharmaceuticals Ltd | -- |
| Zai Lab Ltd | 61.66% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -22.45% |
| Return on Assets | -15.00% |
| Return on Invested Capital | -19.41% |
| Profit Margin (Quarterly) | -57.94% |
| Operating Margin (Quarterly) | -60.50% |
| Return on Net Operating Assets | -42.43% |